Gallic Acid Suppresses Colon Cancer Proliferation by Inhibiting SRC and EGFR Phosphorylation

Overview

Journal Exp Ther Med

Specialty Pathology

Date 2021 May 10

PMID 33968169

Citations 17

Authors

Xiaoming Lin

Guangfei Wang

Ping Liu

Lei Han

Tong Wang

Kaili Chen

Yonglin Gao

Affiliations

Soon will be listed here.

Abstract

The aim of the present study was to investigate the effects of gallic acid (GA) on the proliferation and apoptosis of colon cancer cells and to further clarify the mechanism of GA function associated with SRC and EGFR phosphorylation. HCT116 and HT29 cells were treated with different concentrations of GA for 24 h. Cell proliferation and apoptosis were analyzed using plate clone formation and flow cytometry assays, respectively. In addition, the expression of apoptosis-related proteins was examined by western blotting. Furthermore, the level of STAT3, AKT, SRC and EGFR phosphorylation was analyzed by western blotting and immunofluorescence. Subsequently, the SRC inhibitor PP2 and the EGFR inhibitor gefitinib were used to analyze the GA-associated mechanisms. In addition, a xenograft tumor model was established to confirm the effects of GA . The results indicated that GA inhibited cell proliferation and promoted cell apoptosis by upregulating the ratio of cleaved caspase-3/pro-caspase-3 and cleaved caspase-9/pro-caspase-9. Concurrently, GA decreased the level of phosphorylated (p)-SRC, p-EGFR, p-AKT and p-STAT3. Following treatment with PP2 and gefitinib in both cancer cell lines and animal model, GA was demonstrated to inhibit EGFR and SRC phosphorylation to downregulate STAT3 and AKT phosphorylation. , GA prevented tumor growth, promoted tumor apoptosis and decreased the level of p-SRC, p-EGFR, p-STAT3 and p-AKT. In conclusion, GA was indicated to suppress colon cancer proliferation by inhibiting SRC and EGFR phosphorylation.

Citing Articles

Green Tea Components: In Vitro and In Vivo Evidence for Their Anticancer Potential in Colon Cancer.

Randisi F, Perletti G, Marras E, Gariboldi M Cancers (Basel). 2025; 17(4).

PMID: 40002218 PMC: 11853328. DOI: 10.3390/cancers17040623.

Differential effects of β-hydroxybutyrate and α-ketoglutarate on HCT-116 colorectal cancer cell viability under normoxic and hypoxic low-glucose conditions: exploring the role of SRC, HIF1α, ACAT1, and SIRT2 genes.

Badameh P, Akhlaghi Tabar F, Mohammadipoor N, Rezaei R, Ranjkesh R, Maleki M Mol Genet Genomics. 2025; 300(1):14.

PMID: 39833322 DOI: 10.1007/s00438-024-02211-9.

Gallic Acid Enhances the Efficacy of BCR::ABL1 Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia through Inhibition of Mitochondrial Respiration and Modulation of Oncogenic Signaling Pathways.

Xiang W, Sng C, Lam Y, Kok Z, Linn Y, Neo S Int J Mol Sci. 2024; 25(14).

PMID: 39063200 PMC: 11276718. DOI: 10.3390/ijms25147958.

Research progress on antitumor effects of sea buckthorn, a traditional Chinese medicine homologous to food and medicine.

Xu D, Yuan L, Meng F, Lu D, Che M, Yang Y Front Nutr. 2024; 11:1430768.

PMID: 39045282 PMC: 11263281. DOI: 10.3389/fnut.2024.1430768.

Computational analysis of phytocompounds in for its antifibrotic and drug-likeness properties - Herb to drug study.

Gayathri K, Abhinand P, Gayathri V, Prasanna Lakshmi V, Chamundeeswari D, Jiang L Heliyon. 2024; 10(13):e33762.

PMID: 39027607 PMC: 11255509. DOI: 10.1016/j.heliyon.2024.e33762.

References

Venancio V, Cipriano P, Kim H, Antunes L, Talcott S, Mertens-Talcott S . Cocoplum (Chrysobalanus icaco L.) anthocyanins exert anti-inflammatory activity in human colon cancer and non-malignant colon cells. Food Funct. 2016; 8(1):307-314. DOI: 10.1039/c6fo01498d. View

Schmoll H, Tabernero J, Maroun J, De Braud F, Price T, Van Cutsem E . Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial. J Clin Oncol. 2015; 33(32):3733-40. DOI: 10.1200/JCO.2015.60.9107. View

Niemetz R, Gross G . Enzymology of gallotannin and ellagitannin biosynthesis. Phytochemistry. 2005; 66(17):2001-11. DOI: 10.1016/j.phytochem.2005.01.009. View

Agelaki S, Spiliotaki M, Markomanolaki H, Kallergi G, Mavroudis D, Georgoulias V . Caveolin-1 regulates EGFR signaling in MCF-7 breast cancer cells and enhances gefitinib-induced tumor cell inhibition. Cancer Biol Ther. 2009; 8(15):1470-7. DOI: 10.4161/cbt.8.15.8939. View

Bruzzese F, Di Gennaro E, Avallone A, Pepe S, Arra C, Caraglia M . Synergistic antitumor activity of epidermal growth factor receptor tyrosine kinase inhibitor gefitinib and IFN-alpha in head and neck cancer cells in vitro and in vivo. Clin Cancer Res. 2006; 12(2):617-25. DOI: 10.1158/1078-0432.CCR-05-1671. View

Liu Z, Huang H . As2O3-induced c-Src/EGFR/ERK signaling is via Sp1 binding sites to stimulate p21WAF1/CIP1 expression in human epidermoid carcinoma A431 cells. Cell Signal. 2005; 18(2):244-55. DOI: 10.1016/j.cellsig.2005.04.006. View

Yaffe P, Power Coombs M, Doucette C, Walsh M, Hoskin D . Piperine, an alkaloid from black pepper, inhibits growth of human colon cancer cells via G1 arrest and apoptosis triggered by endoplasmic reticulum stress. Mol Carcinog. 2014; 54(10):1070-85. DOI: 10.1002/mc.22176. View

Lee H, Lin C, Kao S, Chou M . Gallic acid induces G1 phase arrest and apoptosis of triple-negative breast cancer cell MDA-MB-231 via p38 mitogen-activated protein kinase/p21/p27 axis. Anticancer Drugs. 2017; 28(10):1150-1156. DOI: 10.1097/CAD.0000000000000565. View

Grothey A, Venook A . Optimizing Adjuvant Therapy for Localized Colon Cancer and Treatment Selection in Advanced Colorectal Cancer. J Natl Compr Canc Netw. 2018; 16(5S):611-615. DOI: 10.6004/jnccn.2018.0038. View

10.

Phan A, Hua T, Kim M, Vo V, Choi J, Kim H . Gallic acid inhibition of Src-Stat3 signaling overcomes acquired resistance to EGF receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer. Oncotarget. 2016; 7(34):54702-54713. PMC: 5342374. DOI: 10.18632/oncotarget.10581. View

11.

Liu X, Jiang J, Chan R, Ji Y, Lu J, Liao Y . Improved Efficacy and Reduced Toxicity Using a Custom-Designed Irinotecan-Delivering Silicasome for Orthotopic Colon Cancer. ACS Nano. 2018; 13(1):38-53. PMC: 6554030. DOI: 10.1021/acsnano.8b06164. View

12.

Giftson J, Jayanthi S, Nalini N . Chemopreventive efficacy of gallic acid, an antioxidant and anticarcinogenic polyphenol, against 1,2-dimethyl hydrazine induced rat colon carcinogenesis. Invest New Drugs. 2009; 28(3):251-9. DOI: 10.1007/s10637-009-9241-9. View

13.

Chen Y, Lin K, Jhang L, Huang C, Lee Y, Chang L . Gallic acid abolishes the EGFR/Src/Akt/Erk-mediated expression of matrix metalloproteinase-9 in MCF-7 breast cancer cells. Chem Biol Interact. 2016; 252:131-40. DOI: 10.1016/j.cbi.2016.04.025. View

14.

Choi H, Song J, Bhatt L, Baek S . Anti-human rhinovirus activity of gallic acid possessing antioxidant capacity. Phytother Res. 2010; 24(9):1292-6. DOI: 10.1002/ptr.3101. View

15.

Sun G, Wang D . Gallic acid from inhibited the growth of esophageal carcinoma cells by suppressing the Hippo signal pathway. Iran J Basic Med Sci. 2020; 23(11):1401-1408. PMC: 7671427. DOI: 10.22038/ijbms.2020.42283.9982. View

16.

Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W . Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004; 350(23):2335-42. DOI: 10.1056/NEJMoa032691. View

17.

Zhang T, Ma L, Wu P, Li W, Li T, Gu R . Gallic acid has anticancer activity and enhances the anticancer effects of cisplatin in non‑small cell lung cancer A549 cells via the JAK/STAT3 signaling pathway. Oncol Rep. 2019; 41(3):1779-1788. DOI: 10.3892/or.2019.6976. View

18.

Liao C, Chen S, Huang H, Wang C . Gallic acid inhibits bladder cancer cell proliferation and migration via regulating fatty acid synthase (FAS). J Food Drug Anal. 2018; 26(2):620-627. PMC: 9322229. DOI: 10.1016/j.jfda.2017.06.006. View

19.

Li J, Hou N, Faried A, Tsutsumi S, Takeuchi T, Kuwano H . Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells. Ann Surg Oncol. 2009; 16(3):761-71. DOI: 10.1245/s10434-008-0260-0. View

20.

Atmaca A, Werner D, Pauligk C, Steinmetz K, Wirtz R, Altmannsberger H . The prognostic impact of epidermal growth factor receptor in patients with metastatic gastric cancer. BMC Cancer. 2012; 12:524. PMC: 3529672. DOI: 10.1186/1471-2407-12-524. View